Patients to get faster access to new treatments and tech
Ground-breaking treatments and technologies tackling key health issues such as cancer, dementia and obesity, are to be fast-tracked to NHS patients quicker than ever in a move welcomed by the Innovation Agency.
It follows the expansion of the recently created Accelerated Access Collaborative (AAC) which brings together the Government, NHS and industry leaders, streamlining national structures which support innovation in the NHS.
The AAC will accelerate the most promising medicines, diagnostic tools and digital services through the clinical development and regulatory approval process so patients can benefit as soon as possible.
It will act as the national front door for innovators looking to get their products funded by the NHS and it will provide a tailored package of support to overcome the barriers in the NHS which can prevent the best medical innovations from reaching patients.
Speeding up the time it takes for NHS patients to access the best innovations is a core part of the NHS Long Term Plan, which is backed by an extra £33.9 billion.
Part of the plan involves extra funding for the Innovation Agency and its 14 fellow Academic Health Science Networks (AHSNs) to deliver Innovation Exchanges, finding the right support for innovative products, promoting regional adoption and spread and increasing health system collaboration.
Innovation Agency Chief Executive Dr Liz Mear recently said:
“For the AHSNs acting as the agents for change on the ground, it is really exciting to see this strengthening of NHS structures and leadership to get innovations to patients, faster.
“We are already experiencing a bigger push from the centre to accelerate the move of new products from the lab bench to the bedside and I am looking forward to seeing the impact of our bold ambition on the people who matter most, our patients.”
The AAC has launched a number of ‘rapid uptake products’ to increase their uptake and use within the NHS, which are being supported by the Innovation Agency and all AHSNs. This includes a blood test for pre-eclampsia, which can diagnose the condition earlier in pregnancy and significantly reduce life-threatening complications.
Together the products have the potential to improve the lives of around 500,000 patients and save the NHS up to £30 million.
Latest News from
Collaborative helps GP practices to find hundreds more people with AF04/11/2019 11:05:00
Over 500 patients have been identified with atrial fibrillation (AF) in the last six months thanks to an improvement programme involving 24 GP practices.
Awards honour outstanding suppliers25/10/2019 16:10:00
A host of health and care organisations and small businesses from across the North West Coast have collected honours in this year’s NHS in the North Excellence in Supply Awards.
Nominate now – North West Coast Research and Innovation Awards25/10/2019 12:25:00
The search is on for the North West Coast’s most inspiring clinical research and innovation teams and individuals whose work is making a difference to people’s lives.
Innovation Agency champions diversity in innovation22/10/2019 09:10:00
A campaign is underway by the Innovation Agency and the AHSN Network to increase diversity in health innovation.
Doddy’s tree replanted at Alder Hey21/10/2019 09:05:00
A tree planted at Alder Hey Children’s Hospital by Liverpool legend Sir Ken Dodd has had a change of location.
New network for innovators16/10/2019 09:10:00
A new network will help health and care innovators to convert their ideas into reality – and ultimately benefit patients.
Awards for North West digital health pioneers14/10/2019 17:05:00
Ten North West health and care organisations have been presented with awards sponsored by the Innovation Agency.